HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Wiwat Tapaneya-Olarn Selected Research

Wiwat Tapaneya-Olarn Research Topics

Disease

2Purpura
01/2016 - 07/2012
1Pancreatitis
01/2016
1Ornithine Carbamoyltransferase Deficiency Disease
11/2013
1Hyperammonemia
11/2013
1Germ Cell and Embryonal Neoplasms (Germ Cell Tumor)
12/2012
1Chronic Kidney Failure (Chronic Renal Failure)
12/2012
1Nephritis
07/2012
1Proteinuria
07/2012
1Hypoalbuminemia
07/2012
1Systemic Vasculitis
11/2002
1Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis
11/2002
1Acidosis
11/2002
1Renal Tubular Acidosis (Distal Renal Tubular Acidosis)
11/2002
1Cystinuria
11/2002
1Graves Disease (Basedow Disease)
11/2002
1Vasculitis (Vasculitides)
11/2002
1Nephrolithiasis
11/2002

Drug/Important Bio-Agent (IBA)

1fibrin fragment D (D-dimer)IBA
01/2016
1OrnithineIBA
11/2013
1AmmoniaIBA
11/2013
1Urea (Carbamide)FDA LinkGeneric
11/2013
1Cisplatin (Platino)FDA LinkGeneric
12/2012
1CreatinineIBA
07/2012
1Proteins (Proteins, Gene)FDA Link
07/2012
1calcium phosphateIBA
11/2002
1CalciumIBA
11/2002
1Calcium OxalateIBA
11/2002
1Cyanides (Isocyanides)IBA
11/2002
1Immunosuppressive Agents (Immunosuppressants)IBA
11/2002
1Methimazole (Thiamazole)FDA LinkGeneric
11/2002
1Nitroprusside (Sodium Nitroprusside)FDA LinkGeneric
11/2002
1PropylthiouracilFDA Link
11/2002
1Antineutrophil Cytoplasmic Antibodies (ANCA)IBA
11/2002
1Potassium CitrateFDA LinkGeneric
11/2002

Therapy/Procedure

1Continuous Renal Replacement Therapy
11/2013
1Aftercare (After-Treatment)
07/2012
1Plasmapheresis
11/2002
1Therapeutics
11/2002